On its thirtieth anniversary, the Flemish Institute for Biotechnology can look back on successes such as Ablynx and Argenx, but top executives Jérôme Van Biervliet and Christine Durinx feel there is a lack of ambition in Europe. ‘Things are moving too slowly; we need to think bigger.’
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
On its thirtieth anniversary, the Flemish Institute for Biotechnology can look back on successes such as Ablynx and Argenx, but top executives Jérôme Van Biervliet and Christine Durinx feel there is a lack of ambition in Europe. ‘Things are moving too slowly; we need to think bigger.’